| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918036 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
Hypofractionated radiotherapy seems to be a safe option in patients with DCIS after breast-conserving surgery while the addition of boost reduces the risk for local recurrence in the presence of positive margins. However, the level of evidence for these observations ranges between very low and low and the results of the ongoing randomized trials are necessary to confirm the results with higher level of evidence.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Cecilia Nilsson, Antonis Valachis,